11.18.25 -- STREAM Edition: Advancing Hematology And Cell Therapy Innovation

Analytical testing for cell and gene therapies presents unique challenges due to the complexity of materials compared to traditional biologics. Ensuring therapeutic efficacy and safety requires detailed characterization and rigorous safety assessments while adhering to stringent regulatory requirements. Ana Fiadeiro of Thermo Fisher Scientific discusses how molecular-based testing, standardized protocols, and robust data management ensures consistent, high-quality outcomes. Watch now to explore key analytical strategies for cell and gene therapy.

Endpoints News founder shares his journey and unpacks the CGT market, from investor sentiment to the challenges of scaling innovation. See what it takes for biotech companies to succeed beyond the lab.

Discover smarter solutions with the new Analytics Knowledge Hub that provides articles, webinars, e-books, and infographics designed to enhance and streamline your bioprocess workflow.

 

Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.

Delve into the dynamic transition towards automation in cell and gene therapy manufacturing as well as the challenges it presents to start ups with industry experts in this webinar.

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

Learn how to properly batch your cell culture vessel, equilibrating media to create a stable and consistent environment for optimal cell growth. This careful setup supports smooth scaling to larger bioprocess systems.

Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency, scalability, and efficiency.

On episode 115 of Cell & Gene: The Podcast, hear Aliya Omer, Vice President and Global Head of Hematology and Cell Therapy at AstraZeneca, share valuable insights from her rich experience leading cell therapy development across multiple top companies.